Physician

Shirley Y Wang, M.D.

According to 2025 Medicare claims, Shirley Wang, M.D. (NPI: 1598831026) practices rheumatology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Johnson, KS. This provider's primary affiliated billing organization is EMPOWER RHEUMATOLOGY LLC (NPI: 1598246837; TIN: 83-1176419) and primary practice location at 66223-2906.

Wang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 365 traditional Medicare patients, billed 159,164 HCPCS/CPT codes, and received $1,583,546 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,624 prescription claims across 436 beneficiaries totaling $3,055,516 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 120 records totaling $2,126. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,073,444 to $1,583,546. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,635,580 to $3,055,516. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	522	53,197	$1,073,444
2016	435	29,627	$699,231
2017	160	2,763	$110,090
2018	163	11,400	$169,979
2019	118	5,281	$124,024
2020	230	31,502	$596,815
2021	305	64,034	$1,075,514
2022	336	113,467	$1,184,013
2023	347	132,881	$1,255,225
2024	365	159,164	$1,583,546

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	456	3,990	$1,635,580
2016	385	3,055	$1,258,014
2017	189	1,295	$290,760
2018	189	1,315	$541,680
2019	172	1,080	$537,576
2020	290	2,107	$1,103,618
2021	366	2,911	$1,925,287
2022	385	2,441	$2,924,351
2023	403	2,319	$3,560,749
2024	436	2,624	$3,055,516

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	73	73	$157
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	344	570	$130
96413	Administration of chemotherapy into vein, 1 hour or less	75	459	$98
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	56	61	$24
96415	Administration of chemotherapy into vein, each additional hour	43	261	$21

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	95	3,052	$845,404
Skyrizi Pen	Risankizumab-Rzaa	35	2,712	$739,602
Stelara	Ustekinumab	13	1,036	$231,760
Orencia Clickject	Abatacept	34	952	$186,560
Enbrel Sureclick	Etanercept	17	476	$121,533

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	120	$2,126	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shirley Y. Wang, M.D.?

Tedicare shows public-source Medicare data for Shirley Y. Wang, M.D. (NPI 1598831026), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shirley Y. Wang, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Shirley Y. Wang, M.D.?

Shirley Y. Wang, M.D. is linked to EMPOWER RHEUMATOLOGY LLC (billing NPI 1598246837) in the available physician profile data.

Does Shirley Y. Wang, M.D. have Open Payments data?

Shirley Y. Wang, M.D. has 120 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.